Quick summary: Mint-Rosuvastatin Tablet products recall; Out of specification (Impurity). Date: 2025-03-26.
Public recall detail
Mint-Rosuvastatin Tablet products recall; Out of specification (Impurity)
2025-03-26
Recall
Safety notice
Quick summary
Recommended action
Recommended action: compare your product with the official notice and follow the instructions published by the official source.
Recall details
Quick summary: Mint-Rosuvastatin Tablet products recall; Out of specification (Impurity). Date: 2025-03-26.
Official details
Affected product details
Structured information extracted from the official recall notice. Confirm the identifiers and instructions in the original notice.
BrandMint Pharmaceuticals Inc, Mint Pharmaceuticals
ProductMint-Rosuvastatin Tablet
IssueHealth products - Product quality
Recall classType III
IdentificationRA-77183
Affected products
BrandMint Pharmaceuticals
ProductMint-Rosuvastatin 10 mg tablet
DIN / NPN / authorizationDIN 02397803
Dosage formTablet
StrengthRosuvastatin calcium 10 mg
Lot14240935B, 14240936B, 14240937A, 14240934A, 14240935A, 14240936A
BrandMint Pharmaceuticals
ProductMint-Rosuvastatin 20 mg tablet
DIN / NPN / authorizationDIN 02397811
Dosage formTablet
StrengthRosuvastatin calcium 20 mg
Lot14240938A, 14240939A, 14240940A, 14240938B, 14240939B, 14240940B
BrandMint Pharmaceuticals
ProductMint-Rosuvastatin 40 mg tablet
DIN / NPN / authorizationDIN 02397838
Dosage formTablet
StrengthRosuvastatin calcium 40 mg
Lot14240941A, 14240942A
Issue
The Impurity is out of specification in the affected lots.
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional official information
AudienceGeneral public Healthcare Industry
CategoryHealth products - Drugs
CompaniesMint Pharmaceuticals Inc 6575 Davand Drive, Mississauga, ON L5T 2M3
Published byHealth Canada
Recall classType III
Alert / recall typeHealth product recall
Identification numberRA-77183
Background{}
CompaniesMint Pharmaceuticals Inc 6575 Davand Drive, Mississauga, ON L5T 2M3
AudiencesGeneral public Healthcare Industry
Source updated2025-03-26
Contains information licensed under the Open Government Licence – Canada. SafetyPulse is independent of the Government of Canada.
FAQ
Frequently asked questions
Answers based on the official recall notice.
Product images
Official product images from Health Canada.
Starting...
Explore more
Related recalls
Similar recalls and safety notices.